A, C., M, B., R, F., P, G. A., E, F., M, R., . . . E, A. (2019). First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: A pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
Citación estilo ChicagoA, Carrato, et al. First-line Single-agent Regorafenib in Frail Patients With Metastatic Colorectal Cancer: A Pilot Phase II Study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). 2019.
Cita MLAA, Carrato, et al. First-line Single-agent Regorafenib in Frail Patients With Metastatic Colorectal Cancer: A Pilot Phase II Study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). 2019.
Precaución: Estas citas no son 100% exactas.